[CLDX] YoY Quarter Result on 30-Jun-2010 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-Aug-2010
Financial Year
2010
Quarter
30-Jun-2010 [#Q2]
Profit Trend
QoQ- -44.71%
YoY- -9.42%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
Revenue 97 2,009 1,952 2,951 2,685 1,962 1,009 -32.29%
PBT -19,016 -13,362 -9,802 -9,191 -8,705 -10,261 -5,505 22.92%
Tax -161 -252 -158 -190 -36 -99 -728 -22.21%
NP -19,016 -13,773 -10,236 -9,525 -8,705 -10,261 -5,505 22.92%
Tax Rate - - - - - - - -
Total Cost 19,113 15,782 12,188 12,476 11,390 12,222 6,515 19.62%
Ratio Analysis
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
NP Margin -19,604.12 -685.56 -524.39 -322.77 -324.21 -523.07 -545.40 81.56%
Per Share
30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 CAGR
EPS -3.53 -3.52 -4.10 -4.49 -8.25 -10.11 -119.26 -44.35%
EPS Diluted -3.53 -3.52 -4.10 -4.49 -8.25 -10.11 -119.26 -44.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.